Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

Ramona Erber, Oleg Gluz, Nils Brünner, Hans Heinrich Kreipe, Enrico Pelz, Ronald Kates, Annette Bartels, Jens Huober, Svjetlana Mohrmann, Zehra Moustafa, Cornelia Liedtke, Volker Möbus, Doris Augustin, Christoph Thomssen, Fritz Jänicke, Marion Kiechle, Walther Kuhn, Ulrike Nitz, Nadia Harbeck, Arndt Hartmann

    8 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences